Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are CD44+/CD24- cells the assumed cancer stem cells in breast cancer?

Experimental oncology - 1 Sept 2017

Ryspayeva D E, Smolanka I I, Dudnichenko А S, Lyashenko A A, Grinevich Yu A, Gurianov V G, Koshubarova M V, Seleznev A A

Abstract excerpt

Identification and characterization of the population of cancer stem cells (CSC) depends on several cellular markers, which combination is specific for the phenotype of CSC in the corresponding tumor. Several markers of CSC have already been identified in breast cancer (BC), but there are no universal indicators that could specifically identify the CSC in BC. AIMS: To determine the validation of the CSC model for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD24 Antigen
Share to Biopsy
Share to Fluorescent Antibody Technique

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyaluronan Receptors

Share to Immunohistochemistry

Share to Neoplasm Grading

Share to Neoplasm Staging

Share to Neoplastic Stem Cells

Source

Identifiers

PMID: 28967636

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Are CD44+/CD24- cells the assumed cancer stem cells in breast cancer?PMID 28967636Read ↗

The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.Semantic proximity Read ↗

Cancer stem cells and their implication in breast cancer.Semantic proximity Read ↗

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.Semantic proximity Read ↗

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinomaSemantic proximity Read ↗

Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.Semantic proximity Read ↗

CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.Semantic proximity Read ↗

Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.Semantic proximity Read ↗

Breast cancer stem cells: an updateSemantic proximity Read ↗

Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.Semantic proximity Read ↗

Breast-cancer stem cells-beyond semantics.Semantic proximity Read ↗

Breast cancer stem cell markers – the rocky road to clinical applicationsSemantic proximity Read ↗

CD44+/CD24‑ phenotype predicts a poor prognosis in triple‑negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.